Nager syndrome is a rare condition that mainly affects the development of the face, hands, and arms. The severity of this disorder varies among affected individuals.
More than half of cases of Nager syndrome are caused by mutations in the SF3B4 gene. The cause of the remainder of cases is unknown; other genes are thought to be involved in the condition.
Nager syndrome is a rare condition. Its prevalence is unknown. More than 75 cases have been reported in the medical literature.
When caused by mutations in the SF3B4 gene, Nager syndrome follows an autosomal dominant inheritance pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most cases result from new mutations in the gene and occur in people with no history of the disorder in their family. Less commonly, an affected person inherits the mutation from one affected parent. Autosomal dominant Nager syndrome may also be caused by mutations in other genes.
Dagmar Wieczorek practices in Duesseldorf, Germany. Wieczorek is rated as an Elite expert by MediFind in the treatment of Acrofacial Dysostosis Nager Type. She is also highly rated in 44 other conditions, according to our data. Her top areas of expertise are Achalasia Microcephaly Syndrome, Microcephaly, Acrofacial Dysostosis Rodriguez Type, and Treacher Collins Syndrome.
Muriel Espinasse-Holder practices in London, United Kingdom. Espinasse-Holder is rated as a Distinguished expert by MediFind in the treatment of Acrofacial Dysostosis Nager Type. She is also highly rated in 25 other conditions, according to our data. Her top areas of expertise are Acrofacial Dysostosis Nager Type, 3M Syndrome, Acrofacial Dysostosis Catania Type, and Hypotonia.
Adrian Collins practices in Okehampton, United Kingdom. Collins is rated as a Distinguished expert by MediFind in the treatment of Acrofacial Dysostosis Nager Type. He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Acrofacial Dysostosis Nager Type, Popliteal Pterygium Syndrome, Primary Localized Cutaneous Amyloidosis, and Small Lymphocytic Lymphoma (SLL).
Published Date: August 01, 2017Published By: National Institutes of Health